Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model

Transplant Immunology

Volumn 25, Issue 2-3, 2011, Pages 141-147

  Eggenhofer, Elke ^a   Renner, Philipp ^a   Soeder, Yorick ^a   Popp, Felix C ^a   Hoogduijn, Martin J ^b   Geissler, Edward K ^a   Schlitt, Hans J ^a   Dahlke, Marc H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allogeneic heart transplantation; Concurrent immunosuppression; Mesenchymal stem cells

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC GRAFT REJECTION; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MESENCHYMAL STEM CELL TRANSPLANTATION; MIXED LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; STEM CELL EXPANSION; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; CYCLOSPORINE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MYCOPHENOLIC ACID; SIROLIMUS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052316642     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.06.002     Document Type: Article

References (32)

1. Geissler E.K., Schlitt H.J. Immunosuppression for liver transplantation. Gut 2009, 58(3):452-463.
2. Hosenpud J.D. Immunosuppression in cardiac transplantation. N Engl J Med 2005, 352(26):2749-2750.
3. Grinyo J.M., Cruzado J.M. Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress. Am J Transplant 2009, 9(11):2447-2452.
4. Fandrich F., Lin X., Chai G.X., Schulze M., Ganten D., Bader M., et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002, 8(2):171-178.
5. Fehr T., Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008, 21(12):1118-1135.
6. Sato Y., Oya H., Yamamoto S., Kobayashi T., Watanabe T., Kokai H., et al. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis. Hepatogastroenterology 2009, 56(89):205-207.
7. Tsui T.Y., Jager M.D., Deiwick A., Klempnauer J., Schlitt H.J. Induction of peripheral tolerance by posttransplant infusion of donor splenocytes. Transplant Proc 2001, 33(1-2):187-188.
8. Dhanireddy K.K., Bruno D.A., Weaver T.A., Xu H., Zhang X., Leopardi F.V., et al. Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates. Am J Transplant 2009, 9(1):124-131.
9. Kawai T., Sogawa H., Boskovic S., Abrahamian G., Smith R.N., Wee S.L., et al. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004, 4(9):1391-1398.
10. Ko S., Deiwick A., Jager M.D., Dinkel A., Rohde F., Fischer R., et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med 1999, 5(11):1292-1297.
11. Wekerle T., Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 1999, 68(4):459-467.
12. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30(1):42-48.
13. Tyndall A., Pistoia V. Mesenchymal stem cells combat sepsis. Nat Med 2009, 15(1):18-20.
14. Ulloa-Montoya F., Kidder B.L., Pauwelyn K.A., Chase L.G., Luttun A., Crabbe A., et al. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 2007, 8(8):R163.
15. Popp F.C., Renner P., Eggenhofer E., Slowik P., Geissler E.K., Piso P., et al. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl 2009, 15(10):1192-1198.
16. English K., Barry F.P., Field-Corbett C.P., Mahon B.P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 2007, 110(2):91-100.
17. Kovacsovics-Bankowski M., Mauch K., Raber A., Streeter P.R., Deans R.J., Maziarz R.T., et al. Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy 2008, 10(7):730-742.
18. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371(9624):1579-1586.
19. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008, 181(6):3933-3946.
20. Chabannes D., Hill M., Merieau E., Rossignol J., Brion R., Soulillou J.P., et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007, 110(10):3691-3694.
21. Ge W., Jiang J., Baroja M.L., Arp J., Zassoko R., Liu W., et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009, 9(8):1760-1772.
22. Popp F.C., Eggenhofer E., Renner P., Slowik P., Lang S.A., Kaspar H., et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008, 20(1-2):55-60.
23. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 2(2):141-150.
24. Niimi M. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J Heart Lung Transplant 2001, 20(10):1123-1128.
25. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969, 57(2):225-229.
26. Inoue S., Popp F.C., Koehl G.E., Piso P., Schlitt H.J., Geissler E.K., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006, 81(11):1589-1595.
27. Renner P., Eggenhofer E., Rosenauer A., Popp F.C., Steinmann J.F., Slowik P., et al. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function. Transplant Proc 2009, 41(6):2607-2611.
28. Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M, Stubbs AP, et al. Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol. Dec 2010;162(3):474-86.
29. Hoogduijn M.J., Crop M.J., Korevaar S.S., Peeters A.M., Eijken M., Maat L.P., et al. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Transplantation 2008, 86(9):1283-1291.
30. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000, 47(2-3):85-118.
31. Pereira G.M., Miller J.F., Shevach E.M. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway. J Immunol 1990, 144(6):2109-2116.
32. Ren G., Zhao X., Zhang L., Zhang J., L'Huillier A., Ling W., et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol. 2010, 184(5):2321-2328.